Systematic literature review to identify prognostic factors of efficacy and safety outcomes of chimeric antigen receptor T-Cell therapies in diffuse large B-Cell lymphoma
- Author(s)
- Julia K Schleifenbaum, Jan-Michel Heger, Jonas Jost, Umberto Rosato, Sybille Riou, Peter Borchmann, Stefan Walzer, Jörg Mahlich
- Abstract
PURPOSE: To identify and summarize clinical factors influencing the efficacy and safety outcomes of CAR-T cell therapies in patients with diffuse large B-cell lymphoma (DLBCL) through a systematic literature review.
METHODS: We performed a systematic literature review to identify factors impacting the efficacy and safety of CAR-T therapies in DLBCL. Articles were searched in PubMed, Cochrane, and EMBASE databases. Key outcomes, including progression-free survival (PFS), overall survival (OS), complete response rate (CRR), objective response rate (ORR), duration of response (DoR), best overall response (BOR), and safety measures (e.g., Immune Effector Cell-Associated Neurotoxicity Syndrome [ICANS], and Cytokine Release Syndrome [CRS]), were extracted according to PRISMA guidelines. A total of 712 articles were identified, with 185 selected for full-text screening. Ultimately, 79 articles met inclusion criteria. Exclusions were primarily due to the absence of relevant outcome data or publication type.
RESULTS: This review highlights several factors that may influence the efficacy and safety of CAR-T therapies in DLBCL, including Eastern Cooperative Oncology Group Performance Status (ECOG PS), International Prognostic Index (IPI) score, disease histology, Ann Arbor disease stage, and elevated LDH levels.
CONCLUSION: The findings of this review can assist clinicians in refining treatment strategies and improving patient outcomes in DLBCL by incorporating these key influencing factors.
- Organisation(s)
- Department of Economics
- External organisation(s)
- Universität zu Köln, MArS Market Access & Pricing Strategy GmbH, Miltenyi Biomedicine, Friedrich-Ebert-Straße 68, 51429, Bergisch Gladbach, Germany., Hochschule Ravensburg-Weingarten, Heinrich-Heine-Universität Düsseldorf
- Journal
- Journal of Cancer Research and Clinical Oncology
- Volume
- 151
- Pages
- 203
- ISSN
- 0171-5216
- DOI
- https://doi.org/10.1007/s00432-025-06249-z
- Publication date
- 07-2025
- Peer reviewed
- Yes
- Austrian Fields of Science 2012
- 303010 Health economics
- Keywords
- ASJC Scopus subject areas
- Oncology, Cancer Research
- Portal url
- https://ucrisportal.univie.ac.at/en/publications/8a10db0a-2ed1-4dd8-a579-dc0dbdb119df